HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

AuthorsAndrea Rinaldi, Maurilio Ponzoni, Silvia Uccella, Davide Rossi, Gianluca Gaidano, Fabio Facchetti, Giancarlo Pruneri, Maria Grazia Tibiletti, Carlo Capella, Emanuele Zucca, Claudio Doglioni, Carlo Catapano, Francesco Bertoni
JournalHematological oncology (Hematol Oncol) Vol. 29 Issue 3 Pg. 164-6 (Sep 2011) ISSN: 1099-1069 [Electronic] England
PMID21416481 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl
  • SYK protein, human
  • Syk Kinase
Topics
  • Cell Line, Tumor
  • Fusion Proteins, bcr-abl (antagonists & inhibitors)
  • Humans
  • Intracellular Signaling Peptides and Proteins (antagonists & inhibitors)
  • Lymphoma, Large B-Cell, Diffuse (drug therapy, enzymology, genetics)
  • Protein Kinase Inhibitors (pharmacology)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Syk Kinase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: